Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (341-350 of 740) with videos related to

Pageof 74
Sort By:
Annals of Hematology|April 21, 2020
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myelomaMagdalini Migkou, Irit Avivi, Maria Gavriatopoulou, et al.
Viruses|March 30, 2023
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective StudyVassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Blood Cancer Journal|December 4, 2025
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myelomaMeletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng, et al.
Blood Cancer Journal|May 2, 2018
Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX studyKenshi Suzuki, Meletios A Dimopoulos, Naoki Takezako, et al.
Cancer|December 13, 2005
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology GroupAristotle Bamias, Lia A Moulopoulos, Aggelos Koutras, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 4, 2015
Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple MyelomaGerasimos-Petros Papassotiriou, Efstathios Kastritis, Maria Gkotzamanidou, et al.
Leukemia & Lymphoma|February 29, 2024
A rare case of TEMPI syndrome (telangiectasias, erythrocytosis, monoclonal gammopathy and ascites) associated with IgM monoclonal gammopathyStavroula Asimakopoulou, Panagiotis Malandrakis, Aikaterini Kamiliou, et al.
American Journal of Hematology|October 1, 2010
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trialEvangelos Eleutherakis-Papaiakovou, Evangelos Kostis, Magda Migkou, et al.
American Journal of Hematology|July 24, 2022
SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignanciesEvangelos Terpos, Despina Fotiou, Vangelis Karalis, et al.
British Journal of Haematology|January 9, 2013
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myelomaMaria T Petrucci, Pilar Giraldo, Paolo Corradini, et al.
Pageof 74

Showing results (341-350 of 740) with videos related to

Sort By:
Pageof 74
Annals of Hematology|April 21, 2020
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myelomaMagdalini Migkou, Irit Avivi, Maria Gavriatopoulou, et al.
Viruses|March 30, 2023
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective StudyVassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Blood Cancer Journal|December 4, 2025
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myelomaMeletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng, et al.
Blood Cancer Journal|May 2, 2018
Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX studyKenshi Suzuki, Meletios A Dimopoulos, Naoki Takezako, et al.
Cancer|December 13, 2005
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology GroupAristotle Bamias, Lia A Moulopoulos, Aggelos Koutras, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 4, 2015
Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple MyelomaGerasimos-Petros Papassotiriou, Efstathios Kastritis, Maria Gkotzamanidou, et al.
Leukemia & Lymphoma|February 29, 2024
A rare case of TEMPI syndrome (telangiectasias, erythrocytosis, monoclonal gammopathy and ascites) associated with IgM monoclonal gammopathyStavroula Asimakopoulou, Panagiotis Malandrakis, Aikaterini Kamiliou, et al.
American Journal of Hematology|October 1, 2010
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trialEvangelos Eleutherakis-Papaiakovou, Evangelos Kostis, Magda Migkou, et al.
American Journal of Hematology|July 24, 2022
SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignanciesEvangelos Terpos, Despina Fotiou, Vangelis Karalis, et al.
British Journal of Haematology|January 9, 2013
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myelomaMaria T Petrucci, Pilar Giraldo, Paolo Corradini, et al.
Pageof 74